Lacosamide Tablet, Film Coated
Product Images NDC 70518-4689

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 70518-4689). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Lacosamide 50mg 70518 4689 00)

Lacosamide 50 mg film coated tablets label for a box containing 30 tablets. The label shows the product name, strength (50 mg), quantity per box, and the NDC number 70518-4689-00. It states the drug is Rx only and repackaged by RemedyRepack Inc., with storage instructions and a caution about transfer of the drug.*

FDA Label Image

Remedy_label (Remedy Label)

Lacosamide Tablet C-V 50 mg film-coated oral tablet in a single tablet package. The label includes the NDC number 70518-4689-01 and indicates repackaging by RemedyRepack Inc., Indiana, PA. The label provides storage instructions, a caution about federal law restricting drug transfer, and tablet description as oval pink with imprint LAC,50.*

FDA Label Image

Laco-fig1.jpg (Laco Fig1)

A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose' comparing seizure reduction percentages for placebo and various doses of Lacosamide across three studies. The y-axis represents seizure reduction percentage, and the x-axis shows placebo and Lacosamide doses in mg/day. The chart highlights statistically significant reductions in seizure frequency with Lacosamide doses versus placebo in all studies presented.*

FDA Label Image

Laco-fig2.jpg (Laco Fig2)

A line graph titled 'Proportion of Patients by Responder Rate for Lacosamide and Placebo Groups in Studies 2, 3, and 4.' The x-axis shows percent of patients from 0 to 100, and the y-axis shows responder rate ranging from -100% (worsening) to 100% (improvement). Four lines represent placebo and lacosamide doses (200 mg/day, 400 mg/day, 600 mg/day) with different patient sample sizes noted in the legend.*

FDA Label Image

Laco-fig3-a (Laco Fig3 A)

A Kaplan-Meier survival curve comparing the proportion of patients over time (in days) between placebo and lacosamide groups. The graph includes risk numbers at various time points and statistical data including p-value, hazard ratio, and confidence interval. Placebo group is represented with a solid line and lacosamide group with a dashed line.*

FDA Label Image

Laco-str (Laco Str)

Chemical structure of the active ingredient lacosamide. The structure includes functional groups such as an amide, an ether, and a phenyl ring, corresponding to the molecular framework of lacosamide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.